Health
Medical
Technology
Fulgent Genetics
$5.339876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$5.33
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.28 (-4.99%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell FLGT and other stocks, options, ETFs, and crypto commission-free!
About
Fulgent Genetics, Inc. Common Stock, also called Fulgent Genetics, is a technology company, which focus on offering comprehensive genetic testing to provide physicians with clinically actionable diagnostic information they can use to improve the overall quality of patient care. Read More Its technology platform includes proprietary gene probes, advanced database algorithms, adaptive learning software, and proprietary laboratory information management systems. The company was founded on May 13, 2016 and is headquartered in Temple City, CA.
CEO
Employees
123
Headquarters
Temple City, California
Founded
2016
Market Cap
97.46M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
14.75K
High Today
$5.48
Low Today
$5.07
Open Price
$5.33
Volume
1.54K
52 Week High
$7.85
52 Week Low
$3.02
Collections
Health
Medical
Technology
Software Service
2016 IPO
US
North America
News
Seeking AlphaMay 11
Fulgent Genetics, Inc. CEO Ming Hsieh on Q1 2019 Results - Earnings Call Transcript
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2019 Results Earnings Conference Call May 7, 2019 4:30 PM ET Company Participants Nicole Borsje - Head of Investor Relations Ming Hsieh - Chief Executive Officer Paul Kim - Chief Financial Officer Conference Call Participants Operator Good day, ladies and gentlemen, and welcome to the Q1 2019 Fulgent Genetics Earnings Conference Call. [Operator Instructions] As a reminder, today’s conference is being recorded. I would now like to introduce your host for confer...
Simply Wall StMay 8
Could Fulgent Genetics, Inc.’s Investor Composition Influence The Stock Price?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! If you want to know who really controls Fulgent Genetics, Inc. (NASDAQ:FLGT), then you’ll have to look at the makeup of its share registry. Institutions will often hold stock in bigger companies, and we expect to see insiders owning a noticeable percentage of the smaller ones. Warren Buffett said that he likes ‘a business with enduring competitive advantages that is run by able and ow...
Yahoo FinanceApr 26
Do Directors Own Fulgent Genetics, Inc. (NASDAQ:FLGT) Shares?
If you want to know who really controls Fulgent Genetics, Inc. (NASDAQ:FLGT), then you'll have to look at the makeup of its share registry. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease their ownership over time. I generally like to see some degree of insider ownership, even if only a little. As Nassim Nicholas Taleb said, 'Don’t tell me what you think, tell me what you have in your portfolio.' Fulgent Genetics is a smaller company w...
Price Paid on Robinhood
50% Higher
Right Now
52 Week Low
$3.02
Average Price Paid
$3.54
52 Week High
$7.85
Earnings
-$0.06
-$0.03
-$0.01
$0.02
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.02 per share
Actual
-$0.06 per share